Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
US-PANTHER Platform Trial in ARDS
NCT07779642Phase 2Not yet recruiting
- Sponsor
- University of Colorado Denver
- Start
- Sep 2026
- Primary completion
- Sep 2029
01
Overview
A Phase 2 trial of simvastatin, baricitinib in acute respiratory distress syndrome (ARDS), sponsored by University of Colorado Denver. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
simvastatinbaricitinib
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT07779642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07779642.